Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleCardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.AuthorsGlassberg, Marilyn K.; Nathan, Steven D.; Lin, Chin-Yu; Morgenthien, Elizabeth A.; Stauffer, John L.; Chou, Willis; Noble, Paul W.PublicationAdvances in Therapy, 2019, Vol 36, Issue 10, p2910ISSN0741-238XPublication typejournal articleDOI10.1007/s12325-019-01052-y